Hypothesis

13 Matching Annotations

Dec 2025
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Targeting Monounsaturated Fatty Acid Metabolism for Radiosensitization of KRAS Mutant 3D Lung Cancer Models

1
1. scibot 05 Dec 2025
  
  in Public
  
  RRID:CVCL_2060
  
  DOI: 10.1158/1535-7163.MCT-24-0213
  
  Resource: (DSMZ Cat# ACC-534, RRID:CVCL_2060)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_2060
  
  What is this?
  
  RRID:CVCL_2060
Visit annotations in context

Tags

RRID:CVCL_2060

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC12137014/
Oct 2025
www.sciencedirect.com www.sciencedirect.com

Optimized arenaviruses with tumor-tropic mutations promote safe anti-tumor efficacy via sustainable immune modulatory properties

1
1. scibot 15 Oct 2025
  
  in Public
  
  DSMZACC534
  
  DOI: 10.1016/j.xcrm.2025.102411
  
  Resource: (DSMZ Cat# ACC-534, RRID:CVCL_2060)
  
  Curator: @areedewitt04
  
  SciCrunch record: RRID:CVCL_2060
  
  What is this?
  
  RRID:CVCL_2060
Visit annotations in context

Tags

RRID:CVCL_2060

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2666379125004847
Jun 2025
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Mutation of SMARCA4 Induces Cancer Cell–Intrinsic Defects in the Enhancer Landscape and Resistance to Immunotherapy

1
1. scibot 11 Jun 2025
  
  in Public
  
  RRID:CVCL_2060
  
  DOI: 10.1158/0008-5472.CAN-24-2054
  
  Resource: (DSMZ Cat# ACC-534, RRID:CVCL_2060)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_2060
  
  What is this?
  
  RRID:CVCL_2060
Visit annotations in context

Tags

RRID:CVCL_2060

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC12127800/
Aug 2024
www.frontiersin.org www.frontiersin.org

Do extracellular vesicles have specific target cells?; Extracellular vesicle mediated embryo maternal communication

1
1. scibot 13 Aug 2024
  
  in Public
  
  HCC-44
  
  DOI: 10.3389/fmolb.2024.1415909
  
  Resource: (DSMZ Cat# ACC-534, RRID:CVCL_2060)
  
  Curator: @dhovakimyan1
  
  SciCrunch record: RRID:CVCL_2060
  
  What is this?
  
  RRID:CVCL_2060
Visit annotations in context

Tags

RRID:CVCL_2060

Annotators

scibot

URL

frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2024.1415909/full
Jul 2024
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

N-Myristoyltransferase Inhibition causes Mitochondrial Iron Overload and Parthanatos in TIM17A-dependent Aggressive Lung Carcinoma

1
1. scibot 27 Jul 2024
  
  in Public
  
  RRID:CVCL_2060
  
  DOI: 10.1158/2767-9764.CRC-23-0428
  
  Resource: (DSMZ Cat# ACC-534, RRID:CVCL_2060)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_2060
  
  What is this?
  
  RRID:CVCL_2060
Visit annotations in context

Tags

RRID:CVCL_2060

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC11270646/
Mar 2024
www.sciencedirect.com www.sciencedirect.com

Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signaling

1
1. scibot 29 Mar 2024
  
  in Public
  
  Cat#ACC-534
  
  DOI: 10.1016/j.chembiol.2024.02.013
  
  Resource: (DSMZ Cat# ACC-534, RRID:CVCL_2060)
  
  Curator: @abever99
  
  SciCrunch record: RRID:CVCL_2060
  
  What is this?
  
  RRID:CVCL_2060
Visit annotations in context

Tags

RRID:CVCL_2060

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2451945624000874
Oct 2021
aacrjournals.org aacrjournals.org

ASTX029, a Novel Dual-mechanism ERK Inhibitor, Modulates Both the Phosphorylation and Catalytic Activity of ERK

1
1. scibot 20 Oct 2021
  
  in Public
  
  RRID:CVCL_2060
  
  DOI: 10.1158/1535-7163.MCT-20-0909
  
  Resource: (DSMZ Cat# ACC-534, RRID:CVCL_2060)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_2060
  
  What is this?
  
  RRID:CVCL_2060
Visit annotations in context

Tags

RRID:CVCL_2060

Annotators

scibot

URL

aacrjournals.org/mct/article/20/10/1757/665735/ASTX029-a-Novel-Dual-mechanism-ERK-Inhibitor
Aug 2021
www.sciencedirect.com www.sciencedirect.com

RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer

1
1. scibot 01 Aug 2021
  
  in Public
  
  RRID:CVCL_2060
  
  DOI: 10.1016/j.chembiol.2019.12.005
  
  Resource: (DSMZ Cat# ACC-534, RRID:CVCL_2060)
  
  Curator: @ethanbadger
  
  SciCrunch record: RRID:CVCL_2060
  
  What is this?
  
  RRID:CVCL_2060 RRIDCUR:Validated
Visit annotations in context

Tags

RRID:CVCL_2060

RRIDCUR:Validated

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2451945619304015
Jul 2021
www.sciencedirect.com www.sciencedirect.com

PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity

1
1. scibot 23 Jul 2021
  
  in Public
  
  ACC 534
  
  DOI: 10.1016/j.ccell.2021.06.018
  
  Resource: (DSMZ Cat# ACC-534, RRID:CVCL_2060)
  
  Curator: @Naa003
  
  SciCrunch record: RRID:CVCL_2060
  
  What is this?
  
  RRID:CVCL_2060 RRIDCUR:Missing
Visit annotations in context

Tags

RRID:CVCL_2060

RRIDCUR:Missing

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610821003408
Sep 2020
www.sciencedirect.com www.sciencedirect.com

A Deregulated HOX Gene Axis Confers an Epigenetic Vulnerability in KRAS-Mutant Lung Cancers

1
1. scibot 07 Sep 2020
  
  in Public
  
  RRID:CVCL_2060
  
  DOI: 10.1016/j.ccell.2020.03.004
  
  Resource: (DSMZ Cat# ACC-534, RRID:CVCL_2060)
  
  Curator: @ethanbadger
  
  SciCrunch record: RRID:CVCL_2060
  
  What is this?
  
  RRIDCUR:Validated RRID:CVCL_2060
Visit annotations in context

Tags

RRID:CVCL_2060

RRIDCUR:Validated

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610820301057
www.sciencedirect.com www.sciencedirect.com

Defining and Targeting Adaptations to Oncogenic KRASG12C Inhibition Using Quantitative Temporal Proteomics

1
1. scibot 04 Sep 2020
  
  in Public
  
  HCC44
  
  DOI: 10.1016/j.celrep.2020.03.021
  
  Resource: (DSMZ Cat# ACC-534, RRID:CVCL_2060)
  
  Curator: @ethanbadger
  
  SciCrunch record: RRID:CVCL_2060
  
  What is this?
  
  RRIDCUR:Missing RRID:CVCL_2060
Visit annotations in context

Tags

RRID:CVCL_2060

RRIDCUR:Missing

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2211124720303284
Jan 2020
onlinelibrary.wiley.com onlinelibrary.wiley.com

Radioresistance of KRAS/TP53‐Mutated Lung Cancer can be overcome by Radiation Dose Escalation or EGFR Tyrosine Kinase Inhibition In Vivo

1
1. scibot 13 Jan 2020
  
  in Public
  
  RRID:CVCL_2060
  
  DOI: 10.1002/ijc.32598
  
  Resource: (DSMZ Cat# ACC-534, RRID:CVCL_2060)
  
  Curator: @Naa003
  
  SciCrunch record: RRID:CVCL_2060
  
  What is this?
  
  RRID:CVCL_2060 RRIDCUR:Validated
Visit annotations in context

Tags

RRID:CVCL_2060

RRIDCUR:Validated

Annotators

scibot

URL

onlinelibrary.wiley.com/doi/full/10.1002/ijc.32598
Nov 2018
www.sciencedirect.com www.sciencedirect.com

Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor

1
1. scibot 05 Nov 2018
  
  in Public
  
  ACC 534
  
  Curator: @Jmenke
  
  Resource used:
  
  (KCLB Cat# 70044, RRID:CVCL_2060)
  
  SciCrunch record: RRID:CVCL_2060
  
  Alternate resolvers: SciCrunch xml N2T identifiers.org
  
  What is this?
  
  RRID:CVCL_2060 RRIDCUR:Missing
Visit annotations in context

Tags

RRID:CVCL_2060

RRIDCUR:Missing

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0092867418300412